“Visfatin Promotes Renal Cell Carcinoma Progression: Evidence from Clinical Samples and Cell Line Models” (2025) Journal of Kidney Cancer, 12(3), pp. 58–65. doi:10.15586/jkcvhl.v12i3.427.